Sign In
Buy COR
$263.64
-1.20 (-0.453%)
At Close: Jun 03, 2026
AmerisourceBergen beats profit and revenue expectations, raises full-year outlook
06:44am, Wednesday, 03'rd Aug 2022
AmerisourceBergen Corp. ABC, -2.14% reported Wednesday fiscal third-quarter profit and revenue that beat expectations and raised its full-year outlook, amid strength in its International Healthcare So
Is a Beat Likely for AmerisourceBergen (ABC) in Q3 Earnings?
12:25pm, Wednesday, 27'th Jul 2022
AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
04:59pm, Tuesday, 12'th Jul 2022
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release
04:15pm, Wednesday, 29'th Jun 2022
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2022 on Wednesday, August 3, 2022, pr
Why AmerisourceBergen Is The Best-In-Class Pharmaceuticals Distributor
09:30am, Thursday, 16'th Jun 2022
AmerisourceBergen is one of the "big three" distributors of pharmaceuticals in the United States. In terms of 2021 revenues, it is almost as big as McKesson. The business is recession-resistant, and b
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
12:02pm, Tuesday, 07'th Jun 2022
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Why Is AmerisourceBergen (ABC) Down 4.5% Since Last Earnings Report?
12:49pm, Friday, 03'rd Jun 2022
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
AmerisourceBergen sets $1 billion stock buyback program
06:39am, Wednesday, 01'st Jun 2022
AmerisourceBergen Corp. ABC, -1.32% said Wednesday that it set a new $1 billion stock repurchase program. That represents 3.1% of the pharmaceutical and health care products company's market capitaliz
AmerisourceBergen: A Healthy, Wealthy Stock You Can Count On
10:00am, Monday, 30'th May 2022
AmerisourceBergen is a leading global drug distributor with a strong focus on operational excellence. The company has recently resolved the majority of its legal troubles related to the Opioid crisis,
AmerisourceBergen's stock tanks after largest investor sells $900 million worth of shares
11:06am, Thursday, 12'th May 2022
Shares of AmerisourceBergen Corp. suffered the biggest selloff in more than two years on Thursday, after the drug products and distribution company's largest investor sold off a chunk of its stake.
What's Going On With AmerisourceBergen Shares Today
07:37am, Thursday, 12'th May 2022
Walgreens Boots Alliance Inc (NASDAQ: WBA) has sold 6.0 million shares of AmerisourceBergen Corp (NYSE: ABC) at $150 per share. After the sale, Walgreens Boots Alliance's ownership of Amerisource
AmerisourceBergen (ABC) Q2 Earnings & Revenues Top Estimates
11:17am, Wednesday, 04'th May 2022
AmerisourceBergen's (ABC) fiscal second-quarter results benefit from segmental growth.
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q2 2022 Results - Earnings Call Transcript
10:10am, Wednesday, 04'th May 2022
AmerisourceBergen Corporation (NYSE:ABC ) Q2 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President-Investor Relations Steve Collis - Chairman
AmerisourceBergen (ABC) Tops Q2 Earnings and Revenue Estimates
09:02am, Wednesday, 04'th May 2022
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 7.69% and 0.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
AmerisourceBergen beats earnings expectations, and lifts full-year guidance
06:51am, Wednesday, 04'th May 2022
AmerisourceBergen Corp. ABC, +1.20% reported first-quarter profit and revenue that rose above expectations, amid strength in international healthcare business, and raised its full-year outlook. The he
